VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
1.280
-0.120 (-8.57%)
At close: Jul 8, 2026, 4:00 PM EDT
1.345
+0.065 (5.08%)
After-hours: Jul 8, 2026, 8:00 PM EDT
VolitionRx Employees
VolitionRx had 67 employees as of March 31, 2026. The number of employees decreased by 8 or -10.67% since the number was last reported on December 31, 2025.
Employees
67
Change
-8
Growth
-10.67%
Revenue / Employee
$36,807
Profits / Employee
-$367,135
Market Cap
10.66M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 67 | -8 | -10.67% | 67 | 0 |
| Dec 31, 2025 | 75 | -10 | -11.76% | 75 | 0 |
| Dec 31, 2024 | 85 | -25 | -22.73% | 85 | 0 |
| Dec 31, 2023 | 110 | 6 | 5.77% | 110 | 0 |
| Dec 31, 2022 | 104 | 21 | 25.30% | 104 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 287 |
| Vivos Therapeutics | 270 |
| Co-Diagnostics | 115 |
| Picard Medical | 75 |
| IceCure Medical | 69 |
| Adagio Medical Holdings | 41 |
| enVVeno Medical | 33 |
| Sintx Technologies | 32 |
VNRX News
- 1 day ago - VolitionRx announces data on prognostic value of Nu.Q Cancer Assay - TheFly
- 1 day ago - VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q® Cancer Test - PRNewsWire
- 20 days ago - VolitionRx resumed with a Buy at Maxim - TheFly
- 21 days ago - VolitionRx announces collaboration with Sysmex - TheFly
- 21 days ago - VolitionRx Announces Collaboration with Sysmex - PRNewsWire
- 4 weeks ago - VolitionRx Announces Pricing of $4.6 Million Public Offering - PRNewsWire
- 5 weeks ago - VolitionRx files patent covering Nu.Q technology for Ebola triage - TheFly
- 5 weeks ago - VolitionRx Files New Patent Protecting its Nu.Q® NETs Test for Ebola Triage and Treatment Monitoring - PRNewsWire